Why Us?

  • Unique Data
  • Genetic Variation
  • Accessibility
  • Flexible Process
  • Atractive Terms

Unique Data

Genetic Variation

Accessibility

Flexible Process

Atractive Terms

As the central point of care for Israel’s one million southern residents, the only tertiary hospital in the southern region, and a medical center owned by Clalit, Israel’s largest HMO servicing the majority of the Negev population from birth, Soroka offers a unique scale and scope of data.

For example, on an average year we deliver 17,500 babies, perform 300,000 images, handle 250,000 visits in our ER, and process 40M lab tests for outpatient services. We have one of the largest clinical data repositories in the country, perhaps the only medical center in the world to have complete medical records and data on continuous care throughout a patient’s life, all stored digitally and securely in EMRs. We are also unique in the link we provide between patient records and bio-samples (body fluids, tissue etc.) stored on-site in our bio-bank.

In addition, our location in the desert has driven us to become pioneers in the area of environmental health. We opened the Negev Environmental Health Research Institute (NEHRI), a research center tasked at examining the effects of hot weather and global warming on human health. At the center we correlate independent micro-weather databases with medical data collected from various sources. The combination of data, with access to real patients living in the desert climate, has positioned Soroka as an ideal environment also for developing and testing solutions that address global warming, and health impact of living in desert conditions.

Its strategic location, as a crossroads for various trade routes, including the famous Incense Route, an ancient a network of trade routes which connected the Arabian Peninsula to the Mediterranean in the Hellenistic-Roman period has made the Negev region a melting pot of cultures throughout history. As a result, its population showcases a mosaic of genetic diversity that cannot be found anywhere else.

Servicing a uniquely diverse population roughly comprised of 800k Jews (mainly non-Ashkenazi) and 280k Bedouins, our genetics research lab has deciphered the molecular basis and mechanisms of more than 50 human diseases, including some of the most prevalent and serious hereditary diseases of Arabs and Jews. This has positioned the Soroka Medical Center at the forefront of genetic research, attracting researchers, pharma companies and entrepreneurs from all over the world to work with us.

With everything you need to develop your innovation at your fingertips, partnering with 31ºN means no more wasting valuable time trying to understanding the clinical environment, searching for relevant data, trying to get professional feedback, or guessing business concerns of hospital’s value analysis. With a direct line to facilities, data and people, you can focus your efforts on the important thing - developing groundbreaking solutions that advance healthcare and save lives.

Our location on hospital grounds, creates an optimal environment for researches. Gaining access to KOLs, healthcare professionals, researchers, medical personnel and hospital administration, getting insights and feedback on every aspect of your innovation, like understanding workflows, challenges & needs, testing product functionality & design, and building the roadmap to implementation in a major hospital, commercial considerations and more. Our partners are invited to use Soroka’s clinical facilities, our state-of-the-art laboratories, and clinical environments including hospital units and out-patient clinics. We provide you a testing & validation framework, with access to patients and patient data, and support you along the regulation processes, go-to-market strategy and commercialization.

Last but not least, as one of 14 hospitals owned by Clalit, Israel’s leading HMO, which serves close to 50% of the country’s population, 31ºN is also a gateway to a large-scall rollout, and other opportunities here in Israel.

Our goal at 31ºN is to lower bureaucracy as much as we possibly can, and cut the red tape to shorten the path of innovation into the healthcare system. To achieve this, we created a framework geared towards the needs and pace of the start-up environment.

Adhering to privacy, safety, and regulatory requirements, drives hospitals to adapt rigorous processes and procedures for anyone trying to enter the system. At 31ºN, we understand that a technology start-up does not have the time or capital needed to overcome these strict policies, so we developed a new approach that bridges between both sides of the equation. As part of the Soroka family, we’re in a position to offer our partners a more flexible and agile framework, removing many of the obstacles and limitations that external companies otherwise face, and coming up with creative solutions that only an insider would be able to craft.

We believe that as a leading hospital, it our responsibility to encourage and support healthcare innovation, and even more so to contribute to the development of transformational technologies here in the south of Israel.

By offering attractive terms to companies and entrepreneurs who choose to join any of our programs, we create the financial conditions for tangible success.

To advance the development of technologies and solutions that have an affiliation to Israel’s southern region, we designed a start-up incentive package valued at ILS 50,000, that gives entrepreneurs and early-stage start-ups a head-start on creating the framework for developing their ideas inside Soroka.
Criteria for receiving this incentive is confidential at the discretion of 31ºN management. If you wish to be considered for this package, please apply here.